Abstract

The interesting study of Müller et al. (1) suggests that polyclonal antithymocyte antibodies are responsible for persistent long-term changes in T-cell lymphocyte subsets. The most significant change they found was an expansion of the CD8+bright CD57+ subpopulation. A few years ago, we reported similar abnormalities in the peripheral blood lymphocyte subsets of long-term stable renal transplant recipients with a mean follow-up of 78 months after transplantation (2). The subset of CD57+ cells was significantly expanded. The majority of these cells expressed CD8, but a significant proportion expressed CD4. These CD4+ CD57+ cells were large granular lymphocytes, did not exhibit natural killer activity, and were not able to produce significant level of interleukin-2 upon stimulation with phytohemagglutinin or allogeneic cells (3). Their function has never been precisely determined. Interestingly, the patients we studied received conventional immunosuppression, i.e., high-dose steroids and azathioprine, but never received either cyclosporine or polyclonal antithymocyte antibodies. We agree with Müller et al. that awareness of long-term consequences of any kind of immunosuppression on lymphocyte subsets is necessary. Christophe Legendre Service de Néphrologie; Hôpital Saint-Louis; 75010 Paris, France

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call